Literature DB >> 23422940

Extended spectrum of MBD5 mutations in neurodevelopmental disorders.

Céline Bonnet1, Asma Ali Khan, Emmanuel Bresso, Charlène Vigouroux, Mylène Béri, Sarah Lejczak, Bénédicte Deemer, Joris Andrieux, Christophe Philippe, Anne Moncla, Irina Giurgea, Marie-Dominique Devignes, Bruno Leheup, Philippe Jonveaux.   

Abstract

Intellectual disability (ID) is a clinical sign reflecting diverse neurodevelopmental disorders that are genetically and phenotypically heterogeneous. Just recently, partial or complete deletion of methyl-CpG-binding domain 5 (MBD5) gene has been implicated as causative in the phenotype associated with 2q23.1 microdeletion syndrome. In the course of systematic whole-genome screening of individuals with unexplained ID by array-based comparative genomic hybridization, we identified de novo intragenic deletions of MBD5 in three patients leading, as previously documented, to haploinsufficiency of MBD5. In addition, we described a patient with an unreported de novo MBD5 intragenic duplication. Reverse transcriptase-PCR and sequencing analyses showed the presence of numerous aberrant transcripts leading to premature termination codon. To further elucidate the involvement of MBD5 in ID, we sequenced ten coding, five non-coding exons and an evolutionary conserved region in intron 2, in a selected cohort of 78 subjects with a phenotype reminiscent of 2q23.1 microdeletion syndrome. Besides variants most often inherited from an healthy parent, we identified for the first time a de novo nonsense mutation associated with a much more damaging phenotype. Taken together, these results extend the mutation spectrum in MBD5 gene and contribute to refine the associated phenotype of neurodevelopmental disorder.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23422940      PMCID: PMC3831065          DOI: 10.1038/ejhg.2013.22

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  11 in total

1.  Severe intellectual disability and autistic features associated with microduplication 2q23.1.

Authors:  Brian H Y Chung; Sureni Mullegama; Christian R Marshall; Anath C Lionel; Rosanna Weksberg; Lucie Dupuis; Lauren Brick; Chumei Li; Stephen W Scherer; Swaroop Aradhya; D James Stavropoulos; Sarah H Elsea; Roberto Mendoza-Londono
Journal:  Eur J Hum Genet       Date:  2011-11-16       Impact factor: 4.246

2.  Exploring the potential role of disease-causing mutation in a gene desert: duplication of noncoding elements 5' of GRIA3 is associated with GRIA3 silencing and X-linked intellectual disability.

Authors:  Céline Bonnet; Alice Masurel-Paulet; Asma Ali Khan; Mylène Béri-Dexheimer; Patrick Callier; Francine Mugneret; Christophe Philippe; Christel Thauvin-Robinet; Laurence Faivre; Philippe Jonveaux
Journal:  Hum Mutat       Date:  2011-11-28       Impact factor: 4.878

3.  Disruption of an EHMT1-associated chromatin-modification module causes intellectual disability.

Authors:  Tjitske Kleefstra; Jamie M Kramer; Kornelia Neveling; Marjolein H Willemsen; Tom S Koemans; Lisenka E L M Vissers; Willemijn Wissink-Lindhout; Michaela Fenckova; Willem M R van den Akker; Nael Nadif Kasri; Willy M Nillesen; Trine Prescott; Robin D Clark; Koenraad Devriendt; Jeroen van Reeuwijk; Arjan P M de Brouwer; Christian Gilissen; Huiqing Zhou; Han G Brunner; Joris A Veltman; Annette Schenck; Hans van Bokhoven
Journal:  Am J Hum Genet       Date:  2012-06-21       Impact factor: 11.025

4.  2q23.1 microdeletion identified by array comparative genomic hybridisation: an emerging phenotype with Angelman-like features?

Authors:  S Jaillard; C Dubourg; M Gérard-Blanluet; A Delahaye; L Pasquier; C Dupont; C Henry; A-C Tabet; J Lucas; A Aboura; V David; B Benzacken; S Odent; E Pipiras
Journal:  J Med Genet       Date:  2008-09-23       Impact factor: 6.318

5.  Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder.

Authors:  Michael E Talkowski; Sureni V Mullegama; Jill A Rosenfeld; Bregje W M van Bon; Yiping Shen; Elena A Repnikova; Julie Gastier-Foster; Devon Lamb Thrush; Sekar Kathiresan; Douglas M Ruderfer; Colby Chiang; Carrie Hanscom; Carl Ernst; Amelia M Lindgren; Cynthia C Morton; Yu An; Caroline Astbury; Louise A Brueton; Klaske D Lichtenbelt; Lesley C Ades; Marco Fichera; Corrado Romano; Jeffrey W Innis; Charles A Williams; Dennis Bartholomew; Margot I Van Allen; Aditi Parikh; Lilei Zhang; Bai-Lin Wu; Robert E Pyatt; Stuart Schwartz; Lisa G Shaffer; Bert B A de Vries; James F Gusella; Sarah H Elsea
Journal:  Am J Hum Genet       Date:  2011-10-07       Impact factor: 11.025

6.  2q23.1 microdeletion of the MBD5 gene in a female with seizures, developmental delay and distinct dysmorphic features.

Authors:  Grace J Noh; John M Graham
Journal:  Eur J Med Genet       Date:  2012-05-29       Impact factor: 2.708

7.  Haploinsufficiency of MBD5 associated with a syndrome involving microcephaly, intellectual disabilities, severe speech impairment, and seizures.

Authors:  Stephen R Williams; Sureni V Mullegama; Jill A Rosenfeld; Aditi I Dagli; Eli Hatchwell; William P Allen; Charles A Williams; Sarah H Elsea
Journal:  Eur J Hum Genet       Date:  2009-11-11       Impact factor: 4.246

8.  The 2q23.1 microdeletion syndrome: clinical and behavioural phenotype.

Authors:  Bregje W M van Bon; David A Koolen; Louise Brueton; Dominic McMullan; Klaske D Lichtenbelt; Lesley C Adès; Gregory Peters; Kate Gibson; Susan Moloney; Francesca Novara; Tiziano Pramparo; Bernardo Dalla Bernardina; Leonardo Zoccante; Umberto Balottin; Fausta Piazza; Vanna Pecile; Paolo Gasparini; Veronica Guerci; Marleen Kets; Rolph Pfundt; Arjan P de Brouwer; Joris A Veltman; Nicole de Leeuw; Meredith Wilson; Jayne Antony; Santina Reitano; Daniela Luciano; Marco Fichera; Corrado Romano; Han G Brunner; Orsetta Zuffardi; Bert B A de Vries
Journal:  Eur J Hum Genet       Date:  2009-10-07       Impact factor: 4.246

9.  Copy-number variations measured by single-nucleotide-polymorphism oligonucleotide arrays in patients with mental retardation.

Authors:  Janine Wagenstaller; Stephanie Spranger; Bettina Lorenz-Depiereux; Bernd Kazmierczak; Michaela Nathrath; Dagmar Wahl; Babett Heye; Dieter Glaser; Volkmar Liebscher; Thomas Meitinger; Tim M Strom
Journal:  Am J Hum Genet       Date:  2007-08-28       Impact factor: 11.025

10.  The human proteins MBD5 and MBD6 associate with heterochromatin but they do not bind methylated DNA.

Authors:  Sophie Laget; Michael Joulie; Florent Le Masson; Nobuhiro Sasai; Elisabeth Christians; Sriharsa Pradhan; Richard J Roberts; Pierre-Antoine Defossez
Journal:  PLoS One       Date:  2010-08-06       Impact factor: 3.240

View more
  17 in total

1.  A Homozygous Missense Variant in INPP5E Associated with Joubert Syndrome and Related Disorders.

Authors:  Mitesh Shetty; Nimmy Ramdas; Shubhi Sahni; Nandita Mullapudi; Sridevi Hegde
Journal:  Mol Syndromol       Date:  2017-09-08

2.  MBD5 haploinsufficiency is associated with sleep disturbance and disrupts circadian pathways common to Smith-Magenis and fragile X syndromes.

Authors:  Sureni V Mullegama; Loren Pugliesi; Brooke Burns; Zalak Shah; Raiha Tahir; Yanghong Gu; David L Nelson; Sarah H Elsea
Journal:  Eur J Hum Genet       Date:  2014-10-01       Impact factor: 4.246

3.  Exploring the genetic etiology of drug-resistant epilepsy: incorporation of exome sequencing into practice.

Authors:  Mojdeh Mahdiannasser; Ali Rashidi-Nezhad; Reza Shervin Badv; Seyed Mohammad Akrami
Journal:  Acta Neurol Belg       Date:  2022-09-21       Impact factor: 2.471

Review 4.  Clinical and Molecular Aspects of MBD5-Associated Neurodevelopmental Disorder (MAND).

Authors:  Sureni V Mullegama; Sarah H Elsea
Journal:  Eur J Hum Genet       Date:  2016-05-25       Impact factor: 4.246

Review 5.  Abnormalities of the DNA methylation mark and its machinery: an emerging cause of neurologic dysfunction.

Authors:  Jacqueline Weissman; Sakkubai Naidu; Hans T Bjornsson
Journal:  Semin Neurol       Date:  2014-09-05       Impact factor: 3.420

6.  Composite Sleep Problems Observed Across Smith-Magenis Syndrome, MBD5-Associated Neurodevelopmental Disorder, Pitt-Hopkins Syndrome, and ASD.

Authors:  Anusha Gandhi; Dihong Zhou; Joseph Alaimo; Edwin Chon; Michael D Fountain; Sarah H Elsea
Journal:  J Autism Dev Disord       Date:  2021-06

7.  Phenotypic and molecular convergence of 2q23.1 deletion syndrome with other neurodevelopmental syndromes associated with autism spectrum disorder.

Authors:  Sureni V Mullegama; Joseph T Alaimo; Li Chen; Sarah H Elsea
Journal:  Int J Mol Sci       Date:  2015-04-07       Impact factor: 5.923

8.  De novo mutations in moderate or severe intellectual disability.

Authors:  Fadi F Hamdan; Myriam Srour; Jose-Mario Capo-Chichi; Hussein Daoud; Christina Nassif; Lysanne Patry; Christine Massicotte; Amirthagowri Ambalavanan; Dan Spiegelman; Ousmane Diallo; Edouard Henrion; Alexandre Dionne-Laporte; Anne Fougerat; Alexey V Pshezhetsky; Sunita Venkateswaran; Guy A Rouleau; Jacques L Michaud
Journal:  PLoS Genet       Date:  2014-10-30       Impact factor: 5.917

9.  A genomic copy number variant analysis implicates the MBD5 and HNRNPU genes in Chinese children with infantile spasms and expands the clinical spectrum of 2q23.1 deletion.

Authors:  Xiaonan Du; Yu An; Lifei Yu; Renchao Liu; Yanrong Qin; Xiaohong Guo; Daokan Sun; Shuizhen Zhou; Bailin Wu; Yong-Hui Jiang; Yi Wang
Journal:  BMC Med Genet       Date:  2014-05-29       Impact factor: 2.103

10.  Disruption of Mbd5 in mice causes neuronal functional deficits and neurobehavioral abnormalities consistent with 2q23.1 microdeletion syndrome.

Authors:  Vladimir Camarena; Lei Cao; Clemer Abad; Alexander Abrams; Yaima Toledo; Kimi Araki; Masatake Araki; Katherina Walz; Juan I Young
Journal:  EMBO Mol Med       Date:  2014-08       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.